![Stephanie Krebs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/07/2026
Stephanie Krebs is currently Chief Business Officer at Sensei Biotherapeutics, Inc. since 2023.
Formerly, Ms. Krebs was Chief Business Officer at SNIPR Biome ApS from 2022 to 2023.
Education includes graduate studies at The Johns Hopkins University, undergraduate studies at Rochester Christian University, and an MBA from the University of Rochester Simon Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2023 |
| Società | Posizione | Fine |
|---|---|---|
SNIPR Biome ApS
 SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Corporate Officer/Principal | 01/10/2023 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
 University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
